Cyteal
Leg Ulcer
Charles University, Czech RepublicPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Leg Ulcer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Sevoflurane Charles University, Czech Republic | Phase 4 | BB |
Oxygen Jay C. Buckey Jr. | Phase 4 | BB |
Peripheral Blood Mononuclear Cell Mahidol University | Phase 3 | BB |
Allogeneic Adipose-Derived Mesenchymal Stem Cells Medical University of Warsaw | Phase 2 | B |
TREPROSTINIL PHOSPHATE United Therapeutics | Phase 3 | B |
View all 10 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →